… and the „Goldenes Zäpfchen“ 2026 goes to GlaxoSmithKline. 🎉

Im Rahmen unserer diesjährigen Fachtagung „Arzneimittelversorgung mit Zukunft – Was brauchen wir wirklich?“ am 14. März in Göttingen haben wir unseren Negativpreis in diesem Jahr an den Pharmakonzern #GlaxoSmithKline verliehen.

Wir kritisieren deren indirekte #Laienwerbung für #Impfstoff gegen #Gürtelrose und rügen das Unternehmen, mit emotionalisierenden Kampagnen Ängste zu schüren, und so die Nachfrage nach dem Impfstoff zu steigern.

MEZIS fordert eine gesetzliche Nachschärfung des #Heilmittelwerbegesetzes zum besseren Schutz vor #Einflussnahme im #Gesundheitswesen.

Mehr in unserer aktuellen Pressemitteilung unter: https://mezis.de/mezis-negativpreis-goldenes-zaepfchen-an-den-pharmakonzern-glaxosmithkline-vergeben/

Il y a 14 ans : Les échantillons des JO-2012 pourront être testés pendant huit ans https://www.cyclisme-dopage.com/actualite/2012-03-06-lexpress-fr.htm #cyclisme #dopage #JO #Londres2012 #GlaxoSmithKline
Les échantillons des JO-2012 pourront être testés pendant huit ans

Les échantillons prélevés sur les athlètes aux jeux Olympiques de Londres cet été pourront être testés pendant huit ans, afin de permettre aux techniques de dépistage de rattraper celles des tricheurs, ont annoncé mardi les organisateurs.

#Petition #Letter #GlaxoSmithKline

"To: GlaxoSmithKline

We’ve noticed you’ve quietly benefited from £3.4 billion in tax breaks via the Government’s patent box scheme

The scheme was meant to boost innovation and protect jobs, but instead you’ve cut UK jobs and moved manufacturing abroad

So this is an invoice for the full amount you’ve benefitted to date for your broken promises. It’s what you owe us, and our NHS"

Please consider signing this open letter

https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline

Sign the invoice to GlaxoSmithKline

I just signed the massive £3.4 billion invoice going direct to GlaxoSmithKline

Sign the invoice to #GlaxoSmithKline

To: GlaxoSmithKline

We’ve noticed you’ve quietly benefited from £3.4 billion in #tax breaks via Govts patent box scheme

Scheme was meant to boost innovation & protect jobs, but instead you’ve cut #UK#jobs & moved manufacturing abroad

That money could have gone to #NHS #hospitals, training for NHS #nurses, #doctors, or towards care for loved ones

Sign invoice
https://act.38degrees.org.uk/act/Sign-the-invoice-to-GlaxoSmithKline?utm_source=Mastodon

#SaveOurNHS #greed #corruption #CorporateGreed #unemployment #medication

Sign the invoice to GlaxoSmithKline

I just signed the massive £3.4 billion invoice going direct to GlaxoSmithKline

ABL Bio secures major $3.4 billion technology transfer deal with GSK for 'Grabody-B' drug development platform, marking second-largest biotech agreement in South Korea
#YonhapInfomax #ABLBio #GlaxoSmithKline #TechnologyTransfer #GrabodyB #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57545
ABL Bio Exports $3.4 Billion Drug Platform Technology

ABL Bio secures major $3.4 billion technology transfer deal with GSK for 'Grabody-B' drug development platform, marking second-largest biotech agreement in South Korea

Yonhap Infomax

There once was a Danish pharma star,
Whose weight-loss jab soared high and far,
Despite Trump's tariff threat,
Novo Nordisk isn't upset,
Confident in sales, they raise the bar.

#GuardianLimerick #Business #GlaxoSmithKline #Europe #Obesity

https://www.theguardian.com/business/2025/feb/05/novo-nordisk-confident-despite-trump-tariff-risk-as-sales-of-weight-loss-jab-soar

Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar

Europe’s biggest firm, whose sales of Wegovy almost doubled, feels it can ‘meet demands’ of US administration

The Guardian
GSK signs £50m deal with Oxford University on cancer vaccines

Collaboration over at least three years aims to help understand how pre-cancerous cells develop

The Guardian
DNA-Datenbank 23andMe: Ein riskantes Erbe

Hackerangriff, Geldnot, Streit: Der Genanalysefirma 23andMe geht es mies. Viele der 15 Millionen Kunden sorgen sich um ihre DNA-Daten. Aus gutem Grund.

ZEIT ONLINE
GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

The Guardian

By 2019 popular non prescription #heartburn #medication #Zantac was recalled from retail after it was found to contain an #antihistamine that blocks the release of stomach acid called N-nitrosodimethylamine (#NDMA) that is linked to causing #cancer.

#Drug Mfgr #GSK has reached $2.2bn #legalsettlement in US that is supposed to cover 93% of user cases brought thus far.

Previously #GlaxoSmithKline had paid $70m to settle with the lab that discovered the issue, and other big #drugmakers that also marketed the #OTC drug, including #Pfizer and #Sanofi, have already reached sizable settlements.

https://on.ft.com/4eBVq5g #FinancialTimes #GiftLink #Legal #ProductLiability

Subscribe to read